Understanding the complex interactions between IL-8, CXCR1, and CXCR2 within the TME is crucial for developing targeted therapeutic strategies for PCa and addressing tumour progression, dissemination, and treatment resistance. The gene discussed is CXCL8; the disease is neoplasm.